Skip to main content

Table 4 Therapy-related complications and acute exacerbations of IPF in LC-IPF patients (n = 34)

From: Prevalence, risk factors, and impact of lung Cancer on outcomes of idiopathic pulmonary fibrosis: a study from the Middle East

Complications % AEIPF, No. (%) Mortality of AEIPF, No. (%)
Surgery-related complications (n = 3/4) 75% 2/4 (50) 1/2 (50)
 Respiratory failure 25%   
 Pneumonia 50%   
 Empyema 25%   
 Myocardial infarction 25%   
Radiotherapy-related complications (n = 3/5) 60% 2/5 (40) 0/2 (0)
 Radiation pneumonitis 33%   
 Pulmonary infections 33%   
 Respiratory failure 17%   
 Myocardial infarction 17%   
Radio-chemotherapy-related complications (n = 1/2) 50% 0/2 (0) 0/1 (0)
 Radiation pneumonitis 50%   
Chemotherapy-related complications (n = 10/13) 77% 8/13 (61.5) 5/8 (62.5)
 Pancytopenia 30%   
 Pneumonia 40%   
 Respiratory failure 20%   
 Cardiovascular failure 25%   
Total 71% 12/24 (50) 6/12 (50)
  1. LC lung cancer, IPF idiopathic pulmonary fibrosis, AEIPF acute exacerbation of idiopathic pulmonary fibrosis